
Détail de l'auteur
Auteur H. S. CONNERY |
Documents disponibles écrits par cet auteur (2)

![]()
Article : Périodique
E. A. SUAREZ ; K. F. HUYBRECHTS ; L. STRAUB ; S. HERNANDEZ-DIAZ ; H. E. JONES ; H. S. CONNERY ; J. M. DAVIS ; K. J. GRAY ; B. LESTER ; M. TERPLAN ; H. MOGUN ; B. T. BATEMAN |Background: Opioid agonist therapy is strongly recommended for pregnant persons with opioid use disorder. Buprenorphine may be associated with more favorable neonatal and maternal outcomes than methadone, but existing data are limited. Methods:[...]![]()
Article : Périodique
American Psychiatric Association ; Work group on substance use disorders ; Steering committee on practice guidelines ; H. D. KLEBER ; R. D. WEISS ; R. F. ANTON ; T. P. GEORGE ; S. F. GREENFIELD ; T. R. KOSTEN ; C. P. O'BRIEN ; B. J. ROUNSAVILLE ; E. C. STRAIN ; ZIEDONIS D. M. ; HENNESSY G. ; H. S. CONNERY ; J. S. McINTYRE ; S. C. CHARLES ; D. J. ANZIA ; I. A. COOK ; M. T. FINNERTY ; B. R. JOHNSON ; NININGER J. E. ; P. SUMMERGRAD ; S. M. WOODS ; YAGER J. ; PYLES R. ; C. D. CROSS ; R. PEELE ; SHEMO J. P. ; L. LURIE ; R. D. WALKER ; M. A. BARNOVITZ ; S. H. GRAY ; S. SAXENA ; TONNU T. ; KUNKLE R. ; A. B. ALBERT ; FOCHTMANN L. J. ; C. HART ; D. REGIER |Individuals with substance use disorders are heterogeneous with regard to a number of clinically important features and domains of functioning. Consequently, a multimodal approach to treatment is typically required. Care of individuals with subs[...]